The purpose of this research is to estimate the frequency of postoperative lasting muscle weakness in patients receiving Sugammadex after undergoing liver transplant surgery by using electromyographic device (EMG), such as TetraGraph.
Study Type
OBSERVATIONAL
Enrollment
97
Using standard of care TetraGraph device on dominant hand
Using standard of care TetraGraph device on non-dominant hand
Mayo Clinic Florida
Jacksonville, Florida, United States
Incidence of Postoperative Residual Weakness in the Recovery Room
Number of patients to experience postoperative residual weakness after receiving Sugammadex as standard of care for liver transplant surgery. Postoperative residual weakness is defined as train-of-four ratio (TOF) \<0.9. Train-of-four is a test used to measure the level of neuromuscular blockage through delivery of four consecutive stimuli to a nerve. Measurement of the muscle's response (number of twitches 1-4) to the stimuli indicates the degree of paralysis. This is measured by an EMG device placed on the thumb which is also part of standard of care for intraoperative assessment of muscle weakness. The ratio is calculated by comparing the amplitude of the fourth twitch to the first twitch. A TOF \<0.9 indicates residual weakness, a TOF equal to or greater than 0.9 indicates no residual weakness.
Time frame: Approximately 10 minutes of surgery recovery period
ICU Admission
Number of patients to require ICU admission following liver transplantation
Time frame: 30 days
Hospital Length of Stay
Average number of days patients are admitted to the hospital following liver transplantation
Time frame: 30 days
Postoperative Pulmonary Complications
Number of participants who experienced postoperative pulmonary complications defined as pneumonia and respiratory failure
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.